Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Wholesalers Should Take Firm Stance in Price Negotiations: FJPWA
May 13, 2002
- Original Makers to Take Tougher Stance against Patent Infringement
May 13, 2002
- BUSINESS NEWS IN BRIEF
May 13, 2002
- Number of Medical Accidents at Special Function Hospitals Totals over 15,000
May 13, 2002
- Fujisawa: Overseas Sales Exceed \150 Bil.
May 13, 2002
- GL Covering All Clinical Research to Be Drafted
May 13, 2002
- Daiichi Starts Research on Thrombosis Genes with Keio Univ.
May 13, 2002
- Monkasho Drafts GL on Intellectual Property Rights
May 13, 2002
- Sysmex Joins Hands with Keio Univ. for Advanced Medicine Project
May 13, 2002
- MPC Required Additional Report on Fibrinogen Product
May 13, 2002
- Nifedipine Effects Equivalent to those of ACE Inhibitors: Bayer
May 13, 2002
- Secondary Prevention Implementation Rate Needs to Be Increased: JHSF Survey
May 13, 2002
- Toxicogenomic Project Aims at Safety Prediction System
May 13, 2002
- REGULATORY NEWS IN BRIEF
May 13, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
May 13, 2002
- Kenporen, JMA Share Opinions on Review of Medical Fees
May 13, 2002
- 6 New Switch OTC Drugs Recommended for Approval
May 13, 2002
- Specialist System for Surgeons to Begin from June
May 13, 2002
- OTC NEWS IN BRIEF
May 13, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
May 13, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…